These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 19634921

  • 21. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H, Paudel KR, Sharma M.
    JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Insulin resistance, polycystic ovary syndrome and metformin.
    Pugeat M, Ducluzeau PH.
    Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
    Palomba S, Falbo A, Orio F, Zullo F.
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA, Hernández Marín I, Ayala AR.
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The utility of metformin therapy in reproductive-aged women with polycystic ovary syndrome (PCOS).
    Nathan N, Sullivan SD.
    Curr Pharm Biotechnol; 2014 Jun; 15(1):70-83. PubMed ID: 24720592
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal.
    Dunaif A.
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):272-83. PubMed ID: 18364705
    [Abstract] [Full Text] [Related]

  • 34. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.
    Sam S, Ehrmann DA.
    Diabetologia; 2017 Sep; 60(9):1656-1661. PubMed ID: 28770330
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
    Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M.
    Eur J Endocrinol; 2008 Jun; 158(6):793-801. PubMed ID: 18322300
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 40. Insulin and the polycystic ovary syndrome.
    Macut D, Bjekić-Macut J, Rahelić D, Doknić M.
    Diabetes Res Clin Pract; 2017 Aug 01; 130():163-170. PubMed ID: 28646699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.